A protected intermediate for the preparation of semisynthetic insulins

F Borras et al. Biochem J. 1970 Sep.

. 1970 Sep;119(3):24P-25P.

doi: 10.1042/bj1190024pb.

No abstract available

Similar articles

Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
Dorchy H, Duchateau J, Bosson D, D'Hooge D. Dorchy H, et al. Diabete Metab. 1989 May-Jun;15(3):107-10. Diabete Metab. 1989. PMID: 2668052
Human insulin.
Raptis S, Dimitriadis G. Raptis S, et al. Clin Physiol Biochem. 1985;3(1):29-42. Clin Physiol Biochem. 1985. PMID: 3888492
Interactions of short-acting, intermediate-acting and pre-mixed human insulins with free radicals--Comparative EPR examination.
Olczyk P, Komosinska-Vassev K, Ramos P, Mencner Ł, Olczyk K, Pilawa B. Olczyk P, et al. Int J Pharm. 2015 Jul 25;490(1-2):9-15. doi: 10.1016/j.ijpharm.2015.05.022. Epub 2015 May 11. Int J Pharm. 2015. PMID: 25975232
[The use of human insulin in cases of insulin allergy].
Gerö L, Kerényi Z, Bányai Z, Tamás G Jr. Gerö L, et al. Orv Hetil. 1989 May 28;130(22):1159-62. Orv Hetil. 1989. PMID: 2668841 Review. Hungarian.
The past, present, and future of basal insulins.
Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. Pettus J, et al. Diabetes Metab Res Rev. 2016 Sep;32(6):478-96. doi: 10.1002/dmrr.2763. Epub 2015 Nov 25. Diabetes Metab Res Rev. 2016. PMID: 26509843 Review.